Cargando…

Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer

The role of adjuvant chemotherapy in pathological T3N0M0 (pT3N0M0) gastric cancer (GC) remains unclear. The aim of this study was to analyze the prognostic factors of patients with pT3N0M0 GC and to clarify which ones could benefit from adjuvant chemotherapy. A total of 137 patients with pT3N0M0 GC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yi-Fu, Chen, Ming-Yang, Le, Puo-Hsien, Chen, Tsung-Hsing, Kuo, Chia-Jung, Wang, Shang-Yu, Huang, Shih-Chiang, Chou, Wen-Chi, Yeh, Ta-Sen, Hsu, Jun-Te
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054452/ https://www.ncbi.nlm.nih.gov/pubmed/36983734 http://dx.doi.org/10.3390/jpm13030553

Ejemplares similares

Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on “Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553”
por: Chen, Yi-Fu, et al.
Publicado: (2023)

Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone
por: Huang, Ruo-Yi, et al.
Publicado: (2022)

Impact of Pancreatic Resection on Survival in Locally Advanced Resectable Gastric Cancer
por: Chang, Shih-Chun, et al.
Publicado: (2021)

Prognostic Significance of Perineural Invasion in Patients with Stage II/III Gastric Cancer Undergoing Radical Surgery
por: Chen, Yi-Fu, et al.
Publicado: (2022)

Clinicopathological characteristics and outcomes in stage I–III mucinous gastric adenocarcinoma: a retrospective study at a single medical center
por: Hsu, Jun-Te, et al.
Publicado: (2016)

Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer
por: Hsu, Jun-Te, et al.
Publicado: (2015)

Adjuvant chemotherapy in pathological node-negative non-small cell lung cancer
por: Cheng, Ya-Fu, et al.
Publicado: (2023)

Adjuvant Chemotherapy Improves Survival in Stage III Gastric Cancer after D2 Surgery
por: Chang, Shin-Chun, et al.
Publicado: (2018)

Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study
por: Hsu, Jun-Te, et al.
Publicado: (2017)

Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and GALNT14 Genotype
por: Chen, Tsung-Hsing, et al.
Publicado: (2018)

Impact of Metformin Use on Survival in Patients with Gastric Cancer and Diabetes Mellitus Following Gastrectomy
por: Chung, Wai-Shan, et al.
Publicado: (2020)

Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation
por: Le, Puo-Hsien, et al.
Publicado: (2019)

Clinical manifestations, risk factors, and prognostic factors of cytomegalovirus enteritis
por: Yeh, Pai-Jui, et al.
Publicado: (2021)

Adjuvant Chemotherapy for Pathological Node-Positive Disease in Squamous Cell Carcinoma of the Esophagus after Neoadjuvant Chemoradiotherapy Plus Surgery
por: Lin, Jing-Wei, et al.
Publicado: (2022)

The GALNT14 Genotype Predicts Postoperative Outcome of Pancreatic Ductal Adenocarcinoma
por: Chiang, Chun-Cheng, et al.
Publicado: (2019)

Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy
por: Chen, Shin-Cheh, et al.
Publicado: (2021)

Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer
por: Hsu, Jun-Te, et al.
Publicado: (2017)

Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma
por: LE, PUO-HSIEN, et al.
Publicado: (2014)

Comparisons of histological features among primary oral squamous cell carcinomas before and after adjuvant chemotherapy and their lymph node metastatic cancer lesions after adjuvant chemotherapy
por: Cheng, Feng-Chou, et al.
Publicado: (2022)

Prognostic Value of the Metastatic Lymph Node Ratio in Patients With Resectable Carcinoma of Ampulla of Vater
por: Hsu, Chih-Ho, et al.
Publicado: (2015)

Adjuvant Chemotherapy in Node-Negative Advanced Gastric Cancer Patients
por: Su, Jian-wei, et al.
Publicado: (2022)

Prognostic and clinical significance of subcellular CDC27 for patients with rectal adenocarcinoma treated with adjuvant chemotherapy
por: Chang, Chia-Lin, et al.
Publicado: (2022)

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
por: Lee, Po-Hsin, et al.
Publicado: (2023)

Risk Factors, Clinical and Endoscopic Features, and Clinical Outcomes in Patients with Cytomegalovirus Esophagitis
por: Yeh, Pai-Jui, et al.
Publicado: (2022)

Vedolizumab combined with surgical resection successfully treated perforating Crohn’s disease with peritoneal space to rectal and vaginal fistulas: a case report
por: Chung, Meng-Wu, et al.
Publicado: (2021)

The efficacy of adjuvant chemotherapy for older adults with stage II/III gastric cancer: a retrospective cohort study
por: Shih, Yu-Hsuan, et al.
Publicado: (2023)

Adjuvant radiotherapy for patients with pathologic node‐negative esophageal carcinoma: A population based propensity matching analysis
por: Gao, Hui‐Jiang, et al.
Publicado: (2019)

Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?
por: Zabell, Joseph, et al.
Publicado: (2018)

Pancolitis associated with higher mortality risk of cytomegalovirus colitis in patients without inflammatory bowel disease
por: Le, Puo-Hsien, et al.
Publicado: (2018)

Outcomes in Advanced Stage Epithelial Ovarian, Fallopian Tubal, and Peritoneal Cancer after Primary Surgery and Adjuvant Chemotherapies: A Single-Institute Real-World Experience
por: Chang, Chia-Hua, et al.
Publicado: (2020)

Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy
por: Chou, Hsu-Huan, et al.
Publicado: (2019)

Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Yu, Chi-Chang, et al.
Publicado: (2022)

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients
por: Liu, Chia-Hsin, et al.
Publicado: (2015)

N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer: A Modified System Based on Current AJCC Staging
por: Yeh, Chun-Nan, et al.
Publicado: (2015)

Clinical and Pathologic Factors Affecting Lymph Node Yields in Colorectal Cancer
por: Hsu, Ta-Wen, et al.
Publicado: (2013)

Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer
por: Jiang, Bing, et al.
Publicado: (2021)

Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections
por: Kuo, Chia-Jung, et al.
Publicado: (2019)

Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
por: Wang, Shao-Jing, et al.
Publicado: (2022)

The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer
por: Lim, Seung Taek, et al.
Publicado: (2018)

Association of Adjuvant Chemotherapy With Overall Survival Among Women With Small, Node-Negative, Triple-Negative Breast Cancer
por: Oladeru, Oluwadamilola T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pg3a05qcd1nnldu5k4f4ii9k7n